Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PKN
, a novel protein kinase with a catalytic domain homologous to that of the
protein kinase C
(
PKC
) family and unique N-terminal leucine-zipper-like sequences, was identified by molecular cloning from a human hippocampus cDNA library [Mukai and Ono (1994) Biochem. Biophys. Res. Commun. 199, 897-904]. Recently we partially purified recombinant
PKN
from COS7 cells transfected with the cDNA construct encoding human
PKN
, and demonstrated that the recombinant
PKN
was activated by unsaturated fatty acids and limited proteolysis [Mukai, Kitagawa, Shibata et al. (1994) Biochem. Biophys. Res. Commun. 204, 348-356]. The present work has focused on the further purification and characterization of
PKN
from native rat tissue. Immunochemical measurement revealed that
PKN
was found in every tissue, and was especially abundant in testis, spleen and brain; subcellular fractionation of rat brain showed that half of the
PKN
was localized in the soluble cytosolic fraction.
PKN
was purified approx. 8000-fold to apparent homogeneity from the cytosolic fraction of rat testis by DEAE-cellulose chromatography, ammonium sulphate fractionation and chromatography on butyl-Sepharose, heparin-Sepharose, Mono Q and protamine-CH-Sepharose. The enzyme migrates as a band of apparent molecular mass 120 kDa. Using serine-containing peptides based on the pseudosubstrate sequence of
PKC
-delta as phosphate acceptors, the kinase activity was stimulated several-fold by 40 microM unsaturated fatty acids or by detergents such as 0.04% sodium deoxycholate and 0.004% SDS. In the absence of modifiers, protamine sulphate, myelin basic protein and synthetic peptides based on the pseudosubstrate site of PKCs or ribosomal S6 protein were good substrates for phosphorylation by the kinase. In the presence of 40 microM arachidonic acid the kinase activity of
PKN
for these phosphate acceptors was increased 2-18-fold. The autophosphorylation activity of purified
PKN
was partially inhibited by pretreatment with alkaline phosphatase. These properties appear to distinguish
PKN
from many protein kinases isolated previously.
...
PMID:Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis. 765 8
PKN
, a novel protein kinase with catalytic domain homologous to
PKC
family and unique amino terminal leucine zipper-like sequences, was purified partially from COS7 cells transfected with the cDNA construct encoding human
PKN
for enzymatic characterization of the enzyme. Using serine containing synthetic peptides based on
PKC
pseudosubstrate sites as the phosphate acceptors, kinase activities estimated from partially purified
PKN
were not stimulated by Ca2+/phosphatidylserine/diolein but were activated several-fold to several tens-fold by 40 microM unsaturated fatty acids, such as arachidonic acid, linoleic acid, and oleic acid. Autophosphorylation of the immunoprecipitates using anti-
PKN
antiserum was also stimulated by various unsaturated fatty acids. Limited proteolysis of
PKN
with trypsin induced an enhancement of the peptide kinase activity that was almost independent of arachidonic acid.
...
PMID:Activation of PKN, a novel 120-kDa protein kinase with leucine zipper-like sequences, by unsaturated fatty acids and by limited proteolysis. 794 81
A novel protein kinase, designated
PKN
, was identified by molecular cloning from a human hippocampus cDNA library.
PKN
consists of 942 amino acids with a calculated molecular mass of 103,925 daltons.
PKN
has leucine zipper-like sequences in its amino terminal region and contains a catalytic domain that shows strong similarity to that of
protein kinase C
family. Northern blot analysis indicates
PKN
is expressed ubiquitously in human tissues. Antisera against
PKN
identified a 120K dalton protein on SDS polyacrylamide gel electrophoresis when
PKN
was expressed in the insect cells or COS7 cells. Recombinant
PKN
revealed an intrinsic protein kinase activity associated with a 120K protein. This activity was abolished by mutation of the lysine residue in the potential ATP binding site.
...
PMID:A novel protein kinase with leucine zipper-like sequences: its catalytic domain is highly homologous to that of protein kinase C. 813 37
PKN
is a fatty acid-activated serine/threonine kinase that has a catalytic domain highly homologous to that of
protein kinase C
in the carboxyl terminus and a unique regulatory region in the amino terminus. Recently, we reported that the small GTP-binding protein Rho binds to the amino-terminal region of
PKN
and activates
PKN
in a GTP-dependent manner, and we suggested that
PKN
is located on the downstream of Rho in the signal transduction pathway (Amano, M., Mukai, H., Ono, Y., Chihara, K., Matsui, T., Hamajima, Y., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) Science 271, 648-650; Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y. Kakizuka, A., and Narumiya, S. (1996) Science 271, 645-648). To identify other components of the
PKN
pathway such as substrates and regulatory proteins of
PKN
, the yeast two-hybrid strategy was employed. By this screening, a clone encoding the neurofilament L protein, a subunit of neuron-specific intermediate filament, was isolated. The amino-terminal regulatory region of
PKN
was shown to associate with the head-rod domains of other subunits of neurofilament (neurofilament proteins M and H) as well as neurofilament L protein in yeast cells. The direct binding between
PKN
and each subunit of neurofilament was confirmed by using the in vitro translated amino-terminal region of
PKN
and glutathione S-transferase fusion protein containing the head-rod domain of each subunit of neurofilament.
PKN
purified from rat testis phosphorylated each subunit of the native neurofilament purified from bovine spinal cord and the bacterially synthesized head-rod domain of each subunit of neurofilament. Polymerization of neurofilament L protein in vitro was inhibited by phosphorylation of neurofilament L protein by
PKN
. The identification and characterization of the novel interaction with
PKN
may contribute toward the elucidation of mechanisms regulating the function of neurofilament.
...
PMID:PKN associates and phosphorylates the head-rod domain of neurofilament protein. 862 64
PKN
is a newly discovered protein kinase that has been shown to mediate GTPase Rho dependent intracellular signalling. We show in this report that the mouse
PKN
gene is situated at the mouse EP1 prostanoid receptor gene locus and that the two genes are overlapping in a tail-to-tail manner. An "exon trap" strategy was used to identify the overlap phenomenon. By using RT-PCR and 3' RACE we have identified two major
PKN
transcripts that are produced by alternative polyadenylation. The 3' end of the short
PKN
transcript overlaps the 3' untranslated region of the EP1 gene with approximately 280 bp, while the long
PKN
transcript overlaps the whole EP1 gene. Remarkably, none of the three transcripts originating from this locus display the consensus AAUAAA polyadenylation signal. The last seven exons of the
PKN
gene, corresponding to the last third of the
PKN
cDNA, have been recognised in 7.2 kb of continuous genomic sequence that we have collected from the EP1/
PKN
genetic locus. The 3' part of the
PKN
gene is highly fragmented and its intron/exon organisation is reminiscent of that of the Drosophila
protein kinase C
gene. The possibility of a natural antisense regulation of these genes is discussed.
...
PMID:The mouse genes for the EP1 prostanoid receptor and the PKN protein kinase overlap. 885 5
PKN
is a fatty acid- and Rho-activated serine/threonine protein kinase, having a catalytic domain homologous to
protein kinase C
family. To identify components of the
PKN
-signaling pathway such as substrates and regulatory proteins of
PKN
, the yeast two-hybrid strategy was employed. Using the N-terminal region of
PKN
as a bait, cDNAs encoding actin cross-linking protein alpha-actinin, which lacked the N-terminal actin-binding domain, were isolated from human brain cDNA library. The responsible region for interaction between
PKN
and alpha-actinin was determined by in vitro binding analysis using the various truncated mutants of these proteins. The N-terminal region of
PKN
outside the RhoA-binding domain was sufficiently shown to associate with alpha-actinin.
PKN
bound to the third spectrin-like repeats of both skeletal and non-skeletal muscle type alpha-actinin.
PKN
also bound to the region containing EF-hand-like motifs of non-skeletal muscle type alpha-actinin in a Ca2+-sensitive manner and bound to that of skeletal muscle type alpha-actinin in a Ca2+-insensitive manner. alpha-Actinin was co-immunoprecipitated with
PKN
from the lysate of COS7 cells transfected with both expression constructs for
PKN
and alpha-actinin lacking the actin-binding domain. In vitro translated full-length alpha-actinin containing the actin-binding site hardly bound to
PKN
, but the addition of phosphatidylinositol 4, 5-bisphosphate, which is implicated in actin reorganization, stimulated the binding activity of the full-length alpha-actinin with
PKN
. We therefore propose that
PKN
is linked to the cytoskeletal network via a direct association between
PKN
and alpha-actinin.
...
PMID:Interaction of PKN with alpha-actinin. 903 May 26
PKN
is a serine/threonine protein kinase with a catalytic domain homologous to the
protein kinase C
family and unique N-terminal leucine zipper-like sequences. Using analyses with the yeast two-hybrid system and in vitro binding assay, we found that the regulatory domain of
PKN
interacted with vimentin. We then examined whether
PKN
would phosphorylate vimentin in vitro. Vimentin proved to be an excellent substrate for
PKN
, and the phosphorylation of vimentin by
PKN
occurred in the head domain with the result of a nearly complete inhibition of its filament formation in vitro. Similar results were also obtained with another type III intermediate filament protein, glial fibrillary acidic protein (GFAP). These results raise the possibility that
PKN
may regulate filament structures of vimentin and GFAP by domain-specific phosphorylation.
...
PMID:Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN. 917 63
Protein kinase B (PKB, also named as Akt or RAC-protein kinase), that is activated by cellular stress such as heat shock and hyperosmotic treatment, was revealed to be activated by oxidative stress and by chemical stressors of CdCl2 and NaAsO2 by measuring the activity of the enzyme immunoprecipitated from the transfected COS-7 cells. Upon stress treatment, a 30-kDa phosphoprotein was co-immunoprecipitated with PKB from the cells metabolic labeled with [32P]orthophosphate. The phosphoprotein was identified as Hsp27, a small heat shock protein, by immunoblot analysis and co-immunoprecipitation. The association of Hsp27 was specific to PKB as the heat shock protein was not co-immunoprecipitated with other protein kinases such as
protein kinase C
and
PKN
. When the cells were treated with H2O2, PKB was activated gradually and the association of Hsp27 with PKB increased concurrently with the enhancement of PKB activity. In heat-shocked cells, activation of PKB and the association of Hsp27 were detected immediately after the treatment, and the association of the heat shock protein decreased while PKB kept stimulated activity when the cells were further incubated at 37 degrees C. These results suggest that Hsp27 is involved in the activation process of PKB in the signal transduction pathway of various forms of stress.
...
PMID:Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. 923 90
PKN
is a fatty acid-activated serine/threonine protein kinase, having a catalytic domain homologous to
protein kinase C
family.
PKN
has been recently reported to interact with a small GTP-binding protein Rho and cytoskeletal proteins such as neurofilament and alpha-actinin. To identify the new components of the
PKN
-signaling pathway, the yeast two-hybrid system was employed. Using the amino-terminal regulatory domain of
PKN
as a bait, cDNA encoding a neural antigen PCD17, which is recognized by characteristic antibodies of patients with paraneoplastic cerebellar degeneration, was isolated from a human brain cDNA library. The interaction between
PKN
and PCD17 was also determined by the in vitro binding analysis. PCD17 was coimmunoprecipitated with
PKN
from the lysate of COS7 cells transfected with both expression constructs for
PKN
and the amino-terminal region of PCD17. PCD17 was phosphorylated by
PKN
, and the extent of this phosphorylation was enhanced by addition of 40 microM arachidonic acid. The amino-terminal region of PCD17 could form a homodimer in vitro, and PCD17 fused to the Gal4 DNA binding domain showed the transcriptional transactivation of the chloramphenicol acetyltransferase reporter gene linked to 5 Gal4 binding sites and minimal promoter in rat C6 glioma cells. These results suggest the participation of PCD17 in gene expression and lead to a clue for elucidating the
PKN
signaling pathway from the cytosol to the nucleus.
...
PMID:PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. 963 78
Distribution of mRNA encoding
PKN
, a fatty acid and RhoA-activated serine/threonine protein kinase with a catalytic domain highly homologous to that of
protein kinase C
, was investigated in the rat brain using in situ hybridization histochemistry.
PKN
mRNA proved to be heterogenously distributed. The highest signals were observed in the cerebellum, in limbic systems such as olfactory bulb, hippocampal formation and limbic cortex, and in regions involved in central autonomic and neuroendocrine functions, such as hypothalamic ventromedial, dorsomedial, lateroanterior and arcuate nuclei, paraventricular hypothalamic nucleus and locus coeruleus.
PKN
mRNA was also highly expressed in dopaminergic neurons such as the ventral tegmental area and substantia nigra pars compacta, in serotonergic raphe neurons, and in cholinergic neurons such as nucleus diagonal band, nucleus basalis, and lateral dorsal tegmental nucleus. The distribution of
PKN
mRNA differed from that for
PKC
isoforms. As the localization of
PKN
mRNA is heterogeneous,
PKN
may have a specific role in distinct populations of nerve cells.
...
PMID:Localization of PKN mRNA in the rat brain. 972 43
1
2
3
4
5
Next >>